|
|
|
|
|
|
By Don Fink, Dark Horse Consulting | The EMA’s Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials came into effect on July 1, 2025 | |
|
|
|
|
| Risk Mitigation Planning For Pharmaceutical Tariffs | Article | By Steve Kornher, Ph.D., Halloran Consulting | Examine the potential ramifications of proposed tariffs on the pharmaceutical and biotechnology sectors, highlighting critical concerns regarding national security and supply chain stability. |
|
|
|
|
|
.png){kind=logo}
